RIPK4 and neoplasm: A proposed model for RIPK4 action in skin carcinogenesis depicts the phosphorylation of desmosome protein plakophilin-1 (PKP1) by RIPK4, which promotes binding to scaffold protein SHOC2 and the blocking of RAS/MAPK signaling [50], illustrated in Figure 2D.